Reviewing Apyx Medical (NASDAQ:APYX) and Abiomed (NASDAQ:ABMD)
Apyx Medical (NASDAQ:APYX – Get Rating) and Abiomed (NASDAQ:ABMD – Get Rating) are both medical companies, but which is the better business? We will compare the two companies based on the strength of
Apyx Files for FDA Expanded Approval of Renuvion APR Handpiece
Apyx Medical Announces FDA 510k Submission for Renuvion Use Post Liposuction
Apyx Medical Submits 510(k) Premarket Notification For Renuvion APR Handpiece To FDA, Supported By Clinical Study And Real-World Evidence
Apyx Medical Submits 510(k) Premarket Notification For Renuvion APR Handpiece To FDA, Supported By Clinical Study And Real-World Evidence
Recent Uptick Might Appease Apyx Medical Corporation (NASDAQ:APYX) Institutional Owners After Losing 72% Over the Past Year
Apyx Medical Co. (NASDAQ:APYX) Short Interest Update
Apyx Medical Co. (NASDAQ:APYX – Get Rating) was the recipient of a significant drop in short interest during the month of December. As of December 30th, there was short interest totalling 870,400 sha
Analyzing Apyx Medical (NASDAQ:APYX) & EnVVeno Medical (NASDAQ:NVNO)
enVVeno Medical (NASDAQ:NVNO – Get Rating) and Apyx Medical (NASDAQ:APYX – Get Rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies base
Apyx Medical Management to Meet Virtually With Lake Street
Apyx Medical Narrows FY Revenue Guidance, Guides Q4 and FY Revenue Outlook Below Estimates
Apyx Medical Corporation Prelim. Q4 Revenue $12.1M-$12.5M Vs $13.35M Est., Sees Prelim. FY22 Revenue $44M-$44.4M Vs $45.2M Est.
Apyx Medical Corporation Prelim. Q4 Revenue $12.1M-$12.5M vs $13.35M Est., Sees Prelim. FY22 Revenue $44M-$44.4M vs $45.2M Est.
Loading...
No Stock Yet